Get the latest tech news

Groundbreaking Trial To Grow 'Mini Liver' From Patient's Own Lymph Node

An anonymous reader quotes a report from InterestingEngineering: A Pittsburgh-based biotech company has started a one-of-a-kind trial in a patient with a failing liver. Their goal is to grow a functional second liver within the patient's body -- something never achieved before. If effective, it migh...

An anonymous reader quotes a report from InterestingEngineering: A Pittsburgh-based biotech company has started a one-of-a-kind trial in a patient with a failing liver. LyGenesis is currently carrying out a trial in only one patient with end-stage liver disease (ESLD) to test the efficacy of their allogenic regenerative cell therapy. "The lymph nodes then act as in vivo bioreactors, helping the hepatocytes to engraft, proliferate, and generate functional ectopic liver tissue," the press release noted.

Get the Android app